Moderna's focus on cancer boosts stock by 177%, pivoting away from Covid-19 vaccine demand drop.
Moderna's focus on cancer boosts stock by 177%, pivoting away from Covid-19 vaccine demand drop.
Unusual Whales
The company experienced a significant decline in its financial performance as demand for Covid-19 vaccines sharply dropped. Despite this setback, the company remained focused on developing another product or service.
